NCT00004801View on ClinicalTrials.gov

Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

March 31, 1992

Conditions
Hemophilia BFactor IX Deficiency
Interventions
DRUG

monoclonal factor IX replacement therapy

All Listed Sponsors
collaborator

University of North Carolina

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004801 - Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency | Biotech Hunter | Biotech Hunter